| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cilium assembly | FSIP2 TCTN3 CFAP73 FBF1 TTC21B PKHD1 IFT122 WDR54 CPLANE1 DNAH1 | 2.15e-05 | 444 | 89 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | FSIP2 TCTN3 CFAP73 FBF1 TTC21B PKHD1 IFT122 WDR54 CPLANE1 DNAH1 | 3.89e-05 | 476 | 89 | 10 | GO:0044782 |
| GeneOntologyCellularComponent | cilium | FSIP2 RSPH10B2 TCTN3 SLC26A8 DRD2 PPP3CC CFAP73 FBF1 TTC21B PKHD1 TOMM20 IFT122 WDR54 CPLANE1 DNAH1 | 7.22e-06 | 898 | 91 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 8.16e-05 | 238 | 91 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | motile cilium | 1.60e-04 | 355 | 91 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.47e-04 | 214 | 91 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | integrin complex | 3.61e-04 | 32 | 91 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 5.16e-04 | 8 | 91 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | apical part of cell | 1.10e-03 | 592 | 91 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.28e-03 | 487 | 91 | 8 | GO:0016324 | |
| Domain | - | MFHAS1 NTRK2 LRRC1 LRRC69 PIDD1 ZYG11B TLR9 NRROS RABGGTA NLRC4 NLRP3 | 4.54e-07 | 321 | 91 | 11 | 3.80.10.10 |
| Domain | L_dom-like | MFHAS1 NTRK2 LRRC1 LRRC69 PIDD1 ZYG11B TLR9 NRROS RABGGTA NLRC4 NLRP3 | 5.61e-07 | 328 | 91 | 11 | IPR032675 |
| Domain | Leu-rich_rpt | MFHAS1 NTRK2 LRRC1 LRRC69 PIDD1 ZYG11B TLR9 NRROS RABGGTA NLRP3 | 8.01e-07 | 271 | 91 | 10 | IPR001611 |
| Domain | LRR | 6.20e-06 | 201 | 91 | 8 | PS51450 | |
| Domain | LRR_1 | 1.16e-05 | 219 | 91 | 8 | PF00560 | |
| Domain | LRR_8 | 2.02e-05 | 171 | 91 | 7 | PF13855 | |
| Domain | TPR | 3.98e-05 | 129 | 91 | 6 | SM00028 | |
| Domain | TPR_repeat | 4.73e-05 | 133 | 91 | 6 | IPR019734 | |
| Domain | - | 6.84e-05 | 207 | 91 | 7 | 1.25.40.10 | |
| Domain | TPR-contain_dom | 9.23e-05 | 150 | 91 | 6 | IPR013026 | |
| Domain | TPR-like_helical_dom | 1.43e-04 | 233 | 91 | 7 | IPR011990 | |
| Domain | TPR_REGION | 1.56e-04 | 165 | 91 | 6 | PS50293 | |
| Domain | TPR | 1.56e-04 | 165 | 91 | 6 | PS50005 | |
| Domain | Pentatricopeptide_repeat | 1.85e-04 | 23 | 91 | 3 | IPR002885 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.28e-04 | 177 | 91 | 6 | IPR003591 | |
| Domain | LRR_TYP | 2.28e-04 | 177 | 91 | 6 | SM00369 | |
| Domain | Integrin_dom | 2.38e-04 | 25 | 91 | 3 | IPR032695 | |
| Domain | Integrin_alpha | 1.25e-03 | 11 | 91 | 2 | PF00357 | |
| Domain | TPR_8 | 2.20e-03 | 53 | 91 | 3 | PF13181 | |
| Domain | LRR_6 | 2.44e-03 | 55 | 91 | 3 | PF13516 | |
| Domain | Integrin_alpha_C_CS | 2.70e-03 | 16 | 91 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 3.41e-03 | 18 | 91 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 3.41e-03 | 18 | 91 | 2 | PF08441 | |
| Domain | Integrin_alpha | 3.41e-03 | 18 | 91 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 3.41e-03 | 18 | 91 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 3.80e-03 | 19 | 91 | 2 | IPR013519 | |
| Domain | Int_alpha | 3.80e-03 | 19 | 91 | 2 | SM00191 | |
| Pubmed | The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. | 1.90e-07 | 5 | 94 | 3 | 18288107 | |
| Pubmed | Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 3.04e-07 | 52 | 94 | 5 | 20301743 | |
| Pubmed | Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. | 3.80e-07 | 6 | 94 | 3 | 19164858 | |
| Pubmed | 4.13e-06 | 12 | 94 | 3 | 20495560 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30658261 | ||
| Pubmed | Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis. | 7.23e-06 | 2 | 94 | 2 | 33848452 | |
| Pubmed | Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. | 7.23e-06 | 2 | 94 | 2 | 19098911 | |
| Pubmed | The Salmonella pathogenicity island-2 subverts human NLRP3 and NLRC4 inflammasome responses. | 7.23e-06 | 2 | 94 | 2 | 30368901 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 32342103 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 29424023 | ||
| Pubmed | Actions of the NLRP3 and NLRC4 inflammasomes overlap in bone resorption. | 7.23e-06 | 2 | 94 | 2 | 34383985 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 38124741 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 31244842 | ||
| Pubmed | TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. | 7.23e-06 | 2 | 94 | 2 | 21439959 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 33098376 | ||
| Pubmed | ATP13A4 ZNF536 HIVEP1 TRAPPC12 FBF1 AGK NRROS KDM6A ABCC6 USP47 | 9.12e-06 | 638 | 94 | 10 | 31182584 | |
| Pubmed | 1.04e-05 | 16 | 94 | 3 | 23630357 | ||
| Pubmed | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. | 1.26e-05 | 17 | 94 | 3 | 22297845 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 20490635 | ||
| Pubmed | Dock3 stimulates axonal outgrowth via GSK-3β-mediated microtubule assembly. | 2.16e-05 | 3 | 94 | 2 | 22219288 | |
| Pubmed | Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation. | 2.16e-05 | 3 | 94 | 2 | 24798340 | |
| Pubmed | Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. | 2.16e-05 | 3 | 94 | 2 | 21118981 | |
| Pubmed | Actin polymerization as a key innate immune effector mechanism to control Salmonella infection. | 2.16e-05 | 3 | 94 | 2 | 25422455 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22174673 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22777876 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17439323 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 15457444 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 29767567 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 26258904 | ||
| Pubmed | Microglia-neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis. | 2.16e-05 | 3 | 94 | 2 | 36876522 | |
| Pubmed | β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes. | 2.16e-05 | 3 | 94 | 2 | 25582856 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30802690 | ||
| Pubmed | Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. | 2.16e-05 | 3 | 94 | 2 | 17599094 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18614760 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19364881 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 33866944 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 32700178 | ||
| Pubmed | G Protein signaling modulator-3 inhibits the inflammasome activity of NLRP3. | 2.16e-05 | 3 | 94 | 2 | 25271165 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 27750030 | ||
| Pubmed | USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. | 2.16e-05 | 3 | 94 | 2 | 30206189 | |
| Pubmed | Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. | 2.16e-05 | 3 | 94 | 2 | 20603313 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17410198 | ||
| Pubmed | Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. | 2.16e-05 | 3 | 94 | 2 | 19684085 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 38453949 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19596994 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28011505 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 15677700 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19362023 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21124315 | ||
| Pubmed | Sall1 balances self-renewal and differentiation of renal progenitor cells. | 3.37e-05 | 67 | 94 | 4 | 24550112 | |
| Pubmed | 3.71e-05 | 24 | 94 | 3 | 34526512 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 19222370 | ||
| Pubmed | Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cells. | 4.32e-05 | 4 | 94 | 2 | 21273385 | |
| Pubmed | Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. | 4.32e-05 | 4 | 94 | 2 | 18070936 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 27139490 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 11668187 | ||
| Pubmed | Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. | 4.32e-05 | 4 | 94 | 2 | 18490757 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 21957143 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20007575 | ||
| Pubmed | Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. | 4.32e-05 | 4 | 94 | 2 | 20333626 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 28032341 | ||
| Pubmed | Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. | 4.32e-05 | 4 | 94 | 2 | 20368433 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 28961278 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 18768827 | ||
| Pubmed | Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA. | 4.32e-05 | 4 | 94 | 2 | 26687278 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 21037094 | ||
| Pubmed | AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3. | 4.32e-05 | 4 | 94 | 2 | 25775556 | |
| Pubmed | ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. | 4.32e-05 | 4 | 94 | 2 | 17181924 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20385749 | ||
| Pubmed | Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. | 4.32e-05 | 4 | 94 | 2 | 19717512 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 19237518 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 29326099 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20808838 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 18624356 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 32760056 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 32290861 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20713892 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20722078 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 22734669 | ||
| Pubmed | Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. | 4.32e-05 | 4 | 94 | 2 | 18496530 | |
| Pubmed | Candidate genes for panic disorder: insight from human and mouse genetic studies. | 4.32e-05 | 4 | 94 | 2 | 17543035 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 23225887 | ||
| Pubmed | Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. | 4.32e-05 | 4 | 94 | 2 | 27011353 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 5.34e-05 | 27 | 94 | 3 | 31541017 | |
| Pubmed | Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. | 7.19e-05 | 5 | 94 | 2 | 18667412 | |
| Pubmed | Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. | 7.19e-05 | 5 | 94 | 2 | 17935074 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 19812205 | ||
| Pubmed | Structural insights into the human D1 and D2 dopamine receptor signaling complexes. | 7.19e-05 | 5 | 94 | 2 | 33571431 | |
| Pubmed | DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs. | 7.19e-05 | 5 | 94 | 2 | 34860583 | |
| Pubmed | Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. | 7.19e-05 | 5 | 94 | 2 | 27708283 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 24508233 | ||
| Pubmed | Cryopyrin activates the inflammasome in response to toxins and ATP. | 7.19e-05 | 5 | 94 | 2 | 16407890 | |
| Pubmed | Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. | 7.19e-05 | 5 | 94 | 2 | 19918053 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 27045344 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 7490098 | ||
| Pubmed | Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. | 7.19e-05 | 5 | 94 | 2 | 16717117 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 23942123 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 28576980 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 20974980 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 35678562 | ||
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.20e-06 | 115 | 60 | 6 | 769 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.60e-03 | 18 | 60 | 2 | 1160 | |
| GeneFamily | Abhydrolase domain containing | 2.40e-03 | 22 | 60 | 2 | 4 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 2.85e-03 | 24 | 60 | 2 | 615 | |
| GeneFamily | NLR family | 3.09e-03 | 25 | 60 | 2 | 666 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-08 | 145 | 94 | 7 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-06 | 168 | 94 | 6 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.95e-06 | 188 | 94 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-06 | 195 | 94 | 6 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 110 | 94 | 5 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.97e-06 | 198 | 94 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-06 | 199 | 94 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.87e-05 | 168 | 94 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-05 | 177 | 94 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 178 | 94 | 5 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 178 | 94 | 5 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 178 | 94 | 5 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-05 | 179 | 94 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 180 | 94 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 180 | 94 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-05 | 181 | 94 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.32e-05 | 183 | 94 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 184 | 94 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 185 | 94 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 189 | 94 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 94 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 94 | 5 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-05 | 193 | 94 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.56e-05 | 193 | 94 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-05 | 193 | 94 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-05 | 193 | 94 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-05 | 194 | 94 | 5 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 194 | 94 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.98e-05 | 196 | 94 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.12e-05 | 197 | 94 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.12e-05 | 197 | 94 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.12e-05 | 197 | 94 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 6.27e-05 | 198 | 94 | 5 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-05 | 199 | 94 | 5 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-05 | 199 | 94 | 5 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.42e-05 | 199 | 94 | 5 | 6723287924750a2247a07ab6e561066a97b09771 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-05 | 199 | 94 | 5 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.92e-04 | 135 | 94 | 4 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 148 | 94 | 4 | 7c7c87b57aa16f8b91698489df39ace5a3a53df8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.94e-04 | 151 | 94 | 4 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 151 | 94 | 4 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.09e-04 | 153 | 94 | 4 | 64d0f37d7af9b76234f683379e3689771f71fe70 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 154 | 94 | 4 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 154 | 94 | 4 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 154 | 94 | 4 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.25e-04 | 155 | 94 | 4 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 157 | 94 | 4 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 157 | 94 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-04 | 157 | 94 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.51e-04 | 65 | 94 | 3 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.51e-04 | 65 | 94 | 3 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.58e-04 | 159 | 94 | 4 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-04 | 161 | 94 | 4 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.02e-04 | 164 | 94 | 4 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-04 | 164 | 94 | 4 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.11e-04 | 165 | 94 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.11e-04 | 165 | 94 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.31e-04 | 167 | 94 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 4.31e-04 | 167 | 94 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.31e-04 | 167 | 94 | 4 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 167 | 94 | 4 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.50e-04 | 169 | 94 | 4 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-04 | 169 | 94 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 169 | 94 | 4 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.71e-04 | 171 | 94 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-04 | 172 | 94 | 4 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 4.81e-04 | 172 | 94 | 4 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-04 | 173 | 94 | 4 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-04 | 173 | 94 | 4 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.92e-04 | 173 | 94 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-04 | 174 | 94 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-04 | 174 | 94 | 4 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | droplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 174 | 94 | 4 | 773329bb91b97578df138446cf62101dd0dad758 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 174 | 94 | 4 | 7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.03e-04 | 174 | 94 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 175 | 94 | 4 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 175 | 94 | 4 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 175 | 94 | 4 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.25e-04 | 176 | 94 | 4 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.25e-04 | 176 | 94 | 4 | 179b1778e8f6c4cd777cec971960211e7ba5d84a | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.25e-04 | 176 | 94 | 4 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 177 | 94 | 4 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 177 | 94 | 4 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-04 | 178 | 94 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-04 | 178 | 94 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-04 | 178 | 94 | 4 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-04 | 178 | 94 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-04 | 179 | 94 | 4 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.59e-04 | 179 | 94 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 5.59e-04 | 179 | 94 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.59e-04 | 179 | 94 | 4 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.59e-04 | 179 | 94 | 4 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.59e-04 | 179 | 94 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-04 | 179 | 94 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.59e-04 | 179 | 94 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.59e-04 | 179 | 94 | 4 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-04 | 180 | 94 | 4 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.83e-04 | 181 | 94 | 4 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-04 | 181 | 94 | 4 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 5.83e-04 | 181 | 94 | 4 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| Disease | Familial aplasia of the vermis | 3.22e-05 | 20 | 92 | 3 | cv:C0431399 | |
| Disease | Cryopyrin-Associated Periodic Syndromes | 5.75e-05 | 4 | 92 | 2 | C2316212 | |
| Disease | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | 5.75e-05 | 4 | 92 | 2 | C0409818 | |
| Disease | Familial Cold Autoinflammatory Syndrome 1 | 5.75e-05 | 4 | 92 | 2 | C4551895 | |
| Disease | Familial cold urticaria | 5.75e-05 | 4 | 92 | 2 | C0343068 | |
| Disease | Familial cold autoinflammatory syndrome | 5.75e-05 | 4 | 92 | 2 | cv:C0343068 | |
| Disease | Muckle-Wells Syndrome | 9.56e-05 | 5 | 92 | 2 | C0268390 | |
| Disease | Hereditary Autoinflammatory Diseases | 2.00e-04 | 7 | 92 | 2 | C0751422 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 2.00e-04 | 7 | 92 | 2 | C2745997 | |
| Disease | Pituitary Adenoma | 3.41e-04 | 9 | 92 | 2 | C0032000 | |
| Disease | Crohn's disease of large bowel | 3.54e-04 | 44 | 92 | 3 | C0156147 | |
| Disease | IIeocolitis | 3.54e-04 | 44 | 92 | 3 | C0949272 | |
| Disease | schizophrenia (is_marker_for) | 3.54e-04 | 44 | 92 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Crohn's disease of the ileum | 3.54e-04 | 44 | 92 | 3 | C0267380 | |
| Disease | Regional enteritis | 3.54e-04 | 44 | 92 | 3 | C0678202 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 4.26e-04 | 10 | 92 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Polydactyly | 5.01e-04 | 117 | 92 | 4 | C0152427 | |
| Disease | Crohn Disease | 5.17e-04 | 50 | 92 | 3 | C0010346 | |
| Disease | lupus nephritis (is_implicated_in) | 1.42e-03 | 18 | 92 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | Tachycardia | 1.42e-03 | 18 | 92 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 1.42e-03 | 18 | 92 | 2 | C0080203 | |
| Disease | unipolar depression, bipolar disorder | 1.46e-03 | 156 | 92 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | prion disease | 1.59e-03 | 19 | 92 | 2 | EFO_0004720 | |
| Disease | Schizophrenia | 1.75e-03 | 883 | 92 | 9 | C0036341 | |
| Disease | testosterone measurement | TYK2 DOCK3 BMP5 ZNF536 ZFHX4 TRAPPC12 DLGAP4 TTC27 FKBPL C16orf96 NLRC4 | 2.05e-03 | 1275 | 92 | 11 | EFO_0004908 |
| Disease | alcohol use disorder measurement, alcohol dependence | 2.54e-03 | 24 | 92 | 2 | EFO_0009458, MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVGFIQCQLIEGQLQ | 361 | Q7Z4L5 | |
| SLLYQLNQQCQAPGA | 201 | Q5U5X8 | |
| AACQEAQVFGNQLIP | 41 | Q53H12 | |
| PQRINVCGQLNLVCF | 471 | Q4VNC1 | |
| VAIPVFANGNIQCLQ | 201 | Q6P1R4 | |
| LPQLAANAVLFLCGN | 171 | Q8NFM4 | |
| LENATFLLLNGCNPN | 131 | A6NK59 | |
| DFFNNQGIPQLIQLL | 351 | Q5W041 | |
| LNLFQLVCQHQGQPP | 256 | A6NFT4 | |
| KFQQFRGLCEQNLNP | 856 | Q9Y2H0 | |
| QGLICNVNNTCFPQL | 71 | Q8IZY2 | |
| SQAQCLLQQLRELPG | 81 | Q9H3Z7 | |
| SEPNLLVRACNQLGQ | 321 | O94973 | |
| LLPFLQNLCSQVNHL | 331 | Q9H8K7 | |
| QAGAAFQVLQLPQAL | 61 | Q9NPG4 | |
| GACDGLQNLILLNLN | 101 | Q6ZNQ3 | |
| QNQICEGNGIAPLVR | 1026 | Q7Z5J8 | |
| ENIRPNACQIKGNLF | 526 | B2RC85 | |
| CVKFLVQRAQLPGNQ | 51 | Q6ZVH7 | |
| LLNNLGNVCINCRQP | 1066 | Q9HBG6 | |
| QAIDLCLAVLANPGQ | 146 | P17735 | |
| QLTLNGLLQALQSPC | 151 | Q9NPP4 | |
| LPNLDLLNLFQTFCQ | 246 | O43292 | |
| NQLIAGVNFCPVLQV | 161 | Q10469 | |
| GLQALPAQFSCLQRL | 261 | Q9Y4C4 | |
| RALCQAGQPQAINQL | 281 | Q8WXK4 | |
| YLQAQLCNLPQGSLQ | 396 | O15550 | |
| NLLPQFGSQEIIQNC | 6091 | Q5CZC0 | |
| KLLPFNPQLFQNNCG | 256 | O94919 | |
| QINGNFCGLVLNQPL | 381 | P51805 | |
| TPANLLAKGCQLNFI | 61 | P18564 | |
| QLLQPNAGGFLCRQA | 286 | A8MYZ0 | |
| ENLENLFQCLGQVLP | 141 | Q96HM7 | |
| LVQRDIQAFLNQCGA | 101 | Q8N159 | |
| ACTLRAQFLQNLLLP | 191 | O94927 | |
| IFHIQTLGPLQCQPN | 856 | P53708 | |
| QENLPRCGALENLVN | 426 | Q9BTT6 | |
| PNLVSQLCGVFLQNE | 41 | P35410 | |
| LTVQLPFCGRQVLNN | 166 | Q5JQS5 | |
| CPNDNQTAQLLALIL | 501 | Q6ZMV5 | |
| RQEFFQQLLQGCLLP | 6 | Q9H237 | |
| QQLLQGCLLPTAQQG | 11 | Q9H237 | |
| GNLRSQLFPQLCQQL | 1456 | Q9P2D7 | |
| QLFPQLCQQLSDLVA | 1461 | Q9P2D7 | |
| LAAQVQLQCSPAELQ | 566 | Q8TES7 | |
| ANLAACQLLLGQPQL | 256 | Q9UIM3 | |
| PNFQRALFQQVVGAC | 1806 | Q8IZD9 | |
| ANIAIPQCGVLNFKA | 11 | A6NNT2 | |
| QIFQEKLQCVLGQPA | 1066 | Q9H799 | |
| KQFNTQLLCCQPGLI | 331 | P30550 | |
| NNIPALLGKACISFN | 161 | Q6PD62 | |
| INPQNNLGLQLCAET | 261 | P22003 | |
| LNTVNGQCANPLLEL | 556 | Q14767 | |
| ISCPLLFGLNNADQN | 166 | P14416 | |
| LCLLPQLIQHFENPN | 2146 | Q5TBA9 | |
| PLVQFFIGLHCQALQ | 421 | Q8WXE1 | |
| CPVGQFILQNLGLLF | 796 | Q9ULF5 | |
| LVLQLFQAKGCPQLG | 716 | O00411 | |
| NLAFNNLPCIVDFGL | 211 | Q86YC3 | |
| GCQQLLHLCVQQPLQ | 46 | Q9HB75 | |
| LIVDAFLQQLPNCVN | 566 | Q9HAU5 | |
| NPQCNLQKLGLVNSG | 881 | Q96P20 | |
| QLFGISLPNICENDN | 361 | Q9P2F6 | |
| LRLAGLPTQQDCNIQ | 11 | Q8IZC4 | |
| CDFLNLQLQQPLQLA | 201 | Q1RMZ1 | |
| LLCFVLPATNAAQQA | 141 | O95255 | |
| CNAFQNANILILIAG | 746 | Q96RN1 | |
| VLLNLQGNPLCQAVG | 536 | Q92696 | |
| QGNPLCQAVGILEQL | 541 | Q92696 | |
| FDQPAQRGCSQLLLQ | 166 | Q5JWF2 | |
| LAGQNQLLLLCPDFR | 4011 | P08F94 | |
| GLCFLFGSNLRQQPQ | 121 | P11215 | |
| LRGCPLNQQIDFQAF | 316 | Q96B86 | |
| NSLLFNQPLTAGLCQ | 246 | Q96SE0 | |
| NQPLTAGLCQLVERN | 251 | Q96SE0 | |
| LANLQIPNCGLPSAN | 186 | Q16620 | |
| LPLAALLNQQFLCVH | 181 | P48454 | |
| LPVRNNDQALGLTQC | 51 | Q8TC36 | |
| QLCQQQLGLDPNFLR | 2066 | Q86UP3 | |
| NLPVQLAASACVFNL | 376 | Q9C0D3 | |
| LANCQGQPSALRQVN | 61 | Q96MF0 | |
| PRNAVANNNAAVCLL | 651 | Q8WVT3 | |
| NCISQAVNGSQFLPL | 506 | Q9NR96 | |
| LQLNGAPQALAFCSN | 726 | A6NE52 | |
| LNFNLQQLCGPKCRD | 1121 | O95155 | |
| LGLQCLPSDGVQNVN | 576 | P41440 | |
| LCNADNAQIPLANGL | 971 | Q96K76 | |
| LNGAPGFINLCDALN | 231 | P31939 | |
| NLQLLQNCLAVLNGD | 391 | Q9UNH7 | |
| QQAPLAACTLALQAN | 231 | O15090 | |
| GRDQGPNVCALQQIL | 36 | Q15063 | |
| LVPNLQTFCNLAIGC | 551 | O75127 | |
| QANAPLLAGNTCQNV | 306 | Q6NUS6 | |
| IILGICTNFQKNNPV | 346 | Q6P3X3 | |
| AALNIQVGNLCQFLP | 166 | Q8IY18 | |
| QVGNLCQFLPQDKVG | 171 | Q8IY18 | |
| EGLQFQNALGCNPSL | 1056 | P15822 | |
| AIAVCGQPQQLLQVL | 96 | Q15388 | |
| NLLPFVGLNNLGNTC | 76 | O94782 | |
| ALCNNLSVLQLPARN | 16 | Q9H977 | |
| GLAQLLLFAQQICEG | 996 | P29597 | |
| CKLVLNPSAININFN | 131 | Q15049 |